University of Cagliari
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease
Meloni, Mario;Figorilli, Michela;Carta, Manolo;Tamburrino, Ludovica;Sanna, Fabrizio;Defazio, Giovanni;Puligheddu, Monica
2022-01-01
Abstract
Altered serotonergic neurotransmission may contribute to the non-motor features commonly associated with Parkinson's disease (PD) such as sleep disorders. The 5-hydroxytryptophan (5-HTP) is the intermediate metabolite of L-tryptophan in the production of serotonin and melatonin. The purpose of this study was to compare the effects of 5-HTP to placebo on REM sleep behavior disorder (RBD) status in patients with PD.
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| Meloni2021_Article_PreliminaryFindingOfARandomize.pdf open access
Type: versione editoriale
Size 818.04 kB
Format Adobe PDF
|
818.04 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.